Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Precise MRI proton therapy

Dear Sir or Madam,

MRiPT technology marks a significant advance in cancer treatment. In our interview, Prof. Aswin Hoffmann, head of the research group for experimental MR-integrated proton therapy at the Helmholtz-Zentrum Dresden-Rossendorf, explains the challenges and potential benefits of this technology. He emphasizes the importance of real-time MRI imaging for precision in proton therapy and presents possible solutions to technical challenges.

Enjoy reading!

Tim Plato
Editorial team MEDICA-tradefair.com

Table of Contents
Interview: MRiPT technology: prototype for new approaches in cancer treatment
Newsletter Service

MRiPT technology: prototype for new approaches in cancer treatment

Interview – MED TECH & DEVICES
Image: blue prototype for MRI-integrated proton therapy; Copyright: K. Lassig / UKD
MRI-integrated proton therapy (MRiPT) marks a significant advance in cancer treatment by increasing the precision of radiation treatment. In an interview with MEDICA.de, Prof. Aswin Hoffmann presents current technological challenges and highlights the potential benefits of real-time MRI imaging for proton therapy.
Click here for the use case
MRiPT technology: prototype for new approaches in cancer treatment
Image: Banner with the text: Discover the world of MED Tech & DEVICES here; Copyright: Messe Düsseldorf
To top

WellFeet app: Empowering diabetic patients

News

DIGITAL HEALTH
Singaporean researchers, led by Nanyang Technological University, Singapore (NTU Singapore), have introduced a mobile application named WellFeet, designed to educate individuals living with diabetes and their caregivers about the disease and assist them in monitoring daily activities, including medication, physical activity, and diet.
read more
To top

Enhancing cataract surgery in the global south with AI

News

DIGITAL HEALTH
Researchers from the University Hospital Bonn, the University of Bonn, the Sankara Eye Foundation India, and Microsoft Research India are collaborating to improve cataract surgery outcomes in developing regions. Employing artificial intelligence (AI) for video analysis, their initiative aims to address challenges faced in the Global South.
read more
To top

Bioelectronic mesh for cardiac tissue monitoring

News

LAB & DIAGNOSTICS
A team of engineers, led by the University of Massachusetts Amherst, has developed a cutting-edge bioelectronic mesh system integrated with graphene sensors to monitor both mechanical movement and electrical signals in lab-grown human cardiac tissue.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Marius Berlemann, Bernhard J. Stempfle

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.